Abstract

BackgroundPulmonary renal syndrome (PRS), denoting the presence of diffuse alveolar hemorrhage and glomerulonephritis as manifestations of systemic autoimmune disease, is very rare in childhood. The coexistence of circulating anti-neutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane (GBM) disease in children affected by this syndrome is exceptional, with unfavorable outcome in five out of seven patients reported to date. We describe a child with PRS associated with both circulating anti-myeloperoxidase (anti-MPO) ANCA and anti-GBM disease on renal biopsy who was successfully treated with immunosuppressive therapy.Case presentationA 10-year old girl presented with fever, fatigue, malaise, and pallor followed by hemoptysis and severe anemia. Diffuse alveolar hemorrhage was revealed on fiberoptic bronchoscopy. Renal findings consisted of microscopic hematuria, moderate proteinuria, and anti-GBM disease on renal biopsy. ANCA with anti-MPO specificity were present whereas anti-GBM antibodies were on borderline for positivity. Methyl-prednisolone pulses followed by prednisone led to cessation of hemoptysis, marked improvement of lung fuction, and normal finding on chest x-ray within 10 days. An immunosuppressive regimen was then given consisting of prednisone daily for 4 weeks with subsequent taper on alternate day, i.v. cyclophosphamide pulses monthly for 6 doses, followed by mycophenolate mofetil that resulted in normal lung function tests, hemoglobin concentration, and anti-MPO level within four subsequent weeks. During 10-months of follow-up she remained well, her blood pressure and renal function tests were normal, and proteinuria and hematuria gradually resolved.ConclusionWe report a child with an exceptionally rare coexistence of circulating ANCA and anti-GBM disease manifesting as PRS in whom renal disease was not the prominent part of clinical presentation, contrary to other reported pediatric patients. A review of literature on disease with double positive antibodies is also presented. Evaluation of a patient with PRS should include testing for presence of different antibodies. An early diagnosis and rapid institution of aggressive immunosuppressive therapy can induce remission and preserve renal function. Renal prognosis depends on the extent of kidney injury at diagnosis and appropriate treatment.

Highlights

  • Pulmonary renal syndrome (PRS), denoting the presence of diffuse alveolar hemorrhage and glomerulonephritis as manifestations of systemic autoimmune disease, is very rare in childhood

  • Renal prognosis depends on the extent of kidney injury at diagnosis and appropriate treatment

  • We present an exceptional case of a 10-year old girl with diffuse alveolar hemorrhage (DAH) and focal necrotizing crescentic glomerulonephritis (CGN) associated with circulating anti-myeloperoxidase anti-neutrophil cytoplasmic antibody (ANCA) and concomitant anti-glomerular basement membrane (GBM) disease on renal biopsy who was successfully treated with immunosuppressive therapy

Read more

Summary

Conclusion

The pulmonary renal syndrome is very rare in children but represents a serious medical emergency with significant morbidity and mortality. An early diagnosis is crucial and laboratory investigation should be directed toward testing for presence of different antibodies. The coexistence of anti-GBM antibodies and ANCAs is exceptionally rare in children. Rapid institution of plasmapheresis and aggressive immunosuppressive therapy can induce remission and preserve renal function in dual positive patients with PRS. Renal prognosis depends on the extent of kidney injury at diagnosis and appropriate treatment. Competing interests The authors declare that they have no competing interests. Authors’ contributions RB, PM, NS, NS, and MR were the physicians who treated the patient in this report. All authors participated in discussions about the manuscript and approved the final version

Background
Discussion
22. Valentini RP
Findings
24. Kallenberg CG
38. KDIGO Clinical Practice Guidelines for Glomerulonephritis
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.